Simian acquired immune deficiency syndrome (SAIDS) in rhesus macaques (Macaca mulatta) at the California Primate Research Center is caused by a type D retrovirus designated SAIDS retrovirus serotype 1 (SRV-1). This syndrome is characterized by profound immunosuppression and death associated with opportunistic infections. Neurologic signs and lesions have not been described as part of this syndrome. The distribution of SRV-1 in the salivary glands, lymph nodes, spleens, thymuses, and brains of eight virus-infected rhesus macaques was examined by immunohistochemistry. Electron microscopy, in situ RNA hybridization, and Southern blot hybridization were also performed on selected tissues to detect viral particles, RNA, and DNA, respectively. In seven of eight SRV-1-infected animals, the transmembrane envelope glycoprotein (gp2O) of SRV-1 was present in three or more tissues, but never in the brain. In the remaining animal, no viral antigen was detected in any tissue. In this same group of animals, viral nucleic acid was detected in the lymph nodes of six of six animals by Southern blot hybridization, in the salivary glands of two of five animals by both Southern blot and in situ hybridizations, and, surprisingly, in the brains of three of three animals by Southern blot and of three of five animals by in situ hybridization, including the one animal in which viral gp2O was undetectable. None of these animals had neurologic signs or lesions. The detection of viral nucleic acid in the absence of viral antigen in the brain suggests latent SRV-1 infection of the central nervous system.
Simian acquired immune deficiency syndrome (SAIDS) caused by type D retroviruses is a frequent and usually fatal immunosuppressive disease of macaque monkeys maintained at National Institutes of Health regional primate centers (4, 15, 23, 30, 31, 44) . The clinical and pathologic features of SAIDS resemble those of the acquired immune deficiency syndrome (AIDS) of humans (4, 28, 35, 38) . As in AIDS, SAIDS presents a disease spectrum (14, 33) ranging from persistent generalized lymphadenopathy (PGL) and splenomegaly to fulminant SAIDS characterized by severe immune deficiency, opportunistic infections, generalized lymphoid depletion, and hematologic abnormalities (28, 38) .
At the California Primate Research Center, the etiologic agent of SAIDS in rhesus macaques is a type D retrovirus designated SAIDS retrovirus serotype 1 (SRV-1), as shown by the transmission of the disease by tissue-culture-grown (31, 33) and molecularly cloned SRV-1 (14) . Other retroviruses found in macaques, such as simian T-lymphotropic retrovirus type 1, a type C retrovirus, and simian immunodeficiency virus (formerly simian T-lymphotropic retrovirus type III), a lentivirus (1, 5, 22, 25, 37) , have been excluded as etiologic agents of SAIDS in rhesus macaques at the California Primate Research Center (20, 33) .
To better understand the pathogenesis of SAIDS caused by type D retroviruses, we have examined the distribution of SRV-1 in the major lymphoid organs, salivary glands, and brains from eight rhesus macaques infected with SRV-1. This examination has been done by immmunohistochemistry with a monoclonal antibody specific for the 20-kilodalton transmembrane envelope glycoprotein of SRV-1 (gp2O) (18) . Selected tissues were also examined by electron microscopy for viral particles and by in situ RNA hybridization and
We found that SRV-1 was widespread in the tissues examined, with an affinity for germinal centers of lymphoid organs and salivary gland acinar cells. We also provide evidence for latent central nervous system infection in four animals and latent systemic infection in one animal.
MATERIALS AND METHODS Animals, tissues, and virus isolation. Axillary lymph nodes, spleens, thymuses, brains (parietal cortex), and parotid salivary glands were collected at necropsy from eight rhesus monkeys (Macaca mulatta). All animals were euthanatized, four when moribund with terminal SAIDS and four showing only PGL and splenomegaly. All the animals had at least two positive viral cultures prior to necropsy. Infectious SRV-1 was isolated from rhesus monkeys by cocultivation of Raji cells with Ficoll-Hypaque-purified peripheral blood mononuclear cells as previously described (4, 30) . All cultures were subcultured and scored as positive when characteristic syncytia were seen. The presence of SRV-1 was confirmed by indirect immunofluorescence with an anti-SRV-1 gp2O monoclonal antibody (18) . Viral cultures were repeated at necropsy, at which time one animal (21296) was no longer viremic.
Seven of these animals were intravenously inoculated with SRV-1, and one (20263) was a spontaneously occurring SAIDS case from an outdoor corral where SAIDS is endemic (19, 20) . Of the seven experimentally inoculated DISTRIBUTION OF SRV-1 2135 received tissue culture-grown SRV-1. The clinical course of SAIDS, virus status, and antibody status of four of these animals (20343, 21318, 21824, and 21877) have been described in detail in previous reports (18, 21, 32) . Two additional clinically normal rhesus monkeys that were SRV-1 antibody-and virus-negative were chosen from our SAIDS-free colony as uninfected controls.
The selection of the salivary gland, brain, and major lymphoid organs was based on the previous detection of retroviruses in analogous tissues from infected mice (9), cats (7, 10, 40) , goats (3), sheep (39) , gibbons (8, 17) , macaques (6, 11, 21) , and humans (12, 16, 24, 41, 45) .
Tissues were collected immediately after euthanasia, snap frozen in liquid nitrogen-cooled Freon, and stored at -70°C. Adjacent 6-,um cryostat sections were examined by immunohistochemistry and in situ RNA hybridization.
Electron microscopy. Samples of lymph node, spleen, salivary gland, and brain (parietal cortex) collected at necropsy were also fixed in Karnovsky fixative (M. Karnovsky, J. Cell Biol. 27:137A, 1973) for examination by electron microscopy. Tissues were postfixed in 1% osmium tetroxide, serially dehydrated for infiltration, embedded in epoxy, and sectioned at 60 to 90 nm. Sections were stained with lead citrate and uranyl acetate and examined in a Philips EM-400 electron microscope.
Immunohistochemistry. A monoclonal antibody specific for the transmembrane envelope glycoprotein (gp20) of SRV-1 was produced and characterized as previously described (18) . This IgG2a monoclonal antibody was used in an avidin-biotin-peroxidase complex technique (Vector Laboratories, Burlingame, Calif.) with 3-amino-9-ethylcarbazole as the chromogen. Sections of salivary glands and brains from two monkeys (20263 and 21296) were also examined with serum from a rabbit hyperimmunized with whole SRV-1. This serum was reactive with all major viral proteins on Western blot (immunoblot). All sections were lightly counterstained with Mayer's hematoxylin and mounted in Aquamount (Lemer Laboratories, New Haven, Conn.).
Control procedures included omission of the primary antibody, substitution of a heavy-chain-matched monoclonal antibody of irrelevant specificity, and use of normal rabbit serum for rabbit anti-SRV-1. Additional controls included SRV-1-infected and uninfected Raji cells prepared as previously described (30) and matched tissues from the two normal uninfected rhesus monkeys. To ensure reproducibility, each tissue was tested a minimum of three separate times.
Preparation of [35S]RNA. Radioactive RNA probes for in situ hybridization were prepared by using the Riboprobe SP65 vector (with the Salmonella typhimiurium bacteriophage SP6 promoter) containing subcloned full-length DNA from SRV-1: The SP65 plasmids plus inserts were linearized and processed to yield a very pure template for the runoff transcription of radiolabeled RNA. The templates were linearized by using the restriction endonuclease XbaI according to manufacturer guidelines. After restriction endonuclease digestion was complete, the reaction was terminated and the DNA template was extracted with phenol, phenol-chloroform (1:1, vol/vol), and chloroform. The DNA was precipitated twice with 2.5 volumes of 100% ethanol and 0.1 volume of 3 M sodium acetate (pH 6.0). The DNA template was suspended in RNase-free water (29) and stored at 4°C. The linearized templates were used to generate [35S]RNA by using the Promega Biotec Riboprobe reaction conditions to produce RNA probes of high specific activity (34) 20 RI of RNase-free water and subjected to mild alkaline hydrolysis to reduce the RNA to lengths of 50 to 400 base pairs (27) . The processed RNA was stored at -20°C in 2.5 volumes of 100% ethanol-0.1 volume of 3 M sodium acetate.
In situ RNA hybridization. Glass slides were pretreated to reduce nonspecific binding of probes by methods previously described (13) . Tissue sections of salivary gland and brain were collected onto pretreated slides and fixed in ethanolacetic acid (3:1, vol/vol) at room temperature for 15 min, rinsed in 100% ethanol for 5 min, air dried, and stored desiccated at room temperature.
To facilitate probe diffusion, postfixed cryostat sections were pretreated with HCI, SSC (0.15 M NaCl plus 0.015 M sodium citrate; pH 7.4), and proteinase K by previously established methods (13 RESULTS Immunohistochemistry. For seven of eight SRV-1-infected rhesus monkeys, the transmembrane envelope glycoprotein (gp2O) of SRV-1 was detected by immunohistochemistry in three or more tissues, but never in the brain (Table 1) . One animal with PGL and splenomegaly (21296) and the two uninfected controls had no detectable gp2O in any tissue. Seven animals had detectable SRV-1 gp2O in the lymph node and spleen. In these tissues, antigen was detected within germinal centers in a reticular or dendritic staining pattern (Fig. la) . In animals with terminal SAIDS, most germinal centers were positive, whereas in animals with PGL and splenomegaly, only scattered germinal centers stained. SRV-1 gp2O was also detected in aberrant germinal centers in the thymic medulla of one of four animals with PGL and splenomegaly. Detection of SRV-1 in the thymus of the four monkeys with terminal SAIDS was limited to clusters of lymphocytes and rare unidentified stellate cells (Fig. lb) . For these four animals with terminal SAIDS, it was not possible to determine whether the gp2O-positive cells were in the cortex or in the medulla of the thymus because of marked thymic atrophy characterized by lobular collapse and loss of distinction between cortex and medulla. In the spleen of the four animals with terminal SAIDS, perifollicular sinusoidal lining cells were intensely stained (Fig. ic) acinar cells increased with the length of viremia to approximately 80% in animal 20263 which had been viremic for at least 24 months. This observation was also made with two of four animals with PGL and splenomegaly that had positive salivary gland staining. These two animals had been viremic for 18 and 20 months ( (Fig. 2b and c) . In lymph nodes, the viral particles were seen in germinal centers associated with cellular processes (Fig.  2b) Magnification, x600.
with PGL and splenomegaly (Table 1 ). Most cells in the sections had no more than the background of 1 to 2 grains per cell, but in other areas, significant hybridization was evident. In these foci, discrete collections of grains were observed over and around nuclei of salivary gland acinar cells and rare unidentified, scattered cells in the brain. The numbers of silver grains over positive cells in the brain and salivary gland (Fig. 3) were comparable, indicating the presence of comparable amounts of viral RNA. Brain and salivary glands from the two uninfected control animals were negative.
Southern blots were performed on DNA extracted from adjacent areas in these same tissues (Fig. 4) . The salivary glands and brains of those animals positive for SRV-1 RNA by in situ hybridization were also positive for SRV-1 DNA, as was the brain of one animal with terminal SAIDS not tested by in situ hybridization (Table 1) . Southern blots of lymph nodes from each infected animal served as positive controls, and lymph nodes from the two uninfected animals served as negative controls. The intensity of the bands indicated that salivary glands and lymph nodes contained more viral DNA than did the brain. Thus, viral nucleic acid was identified by in situ hybridization, Southern blot, or both in the brains of four of six animals. None of these animals had detectable antigen in the brain ( Table 1 ), suggesting that SRV-1 infection of the central nervous system was latent. One of these animals (21296; location has also been noted in other animal retrovirus models (8, 39, 40) and in humans infected with human immunodeficiency virus (45) .
While germinal centers were the most consistent location for the detection of viral antigen, serous acinar cells of salivary glands were the richest source of viral particles and viral antigens, as detected by electron microscopy and by immunohistochemistry, respectively. This finding correlates with that of previous studies which showed that saliva is a major source of infectious virus and that SAIDS can be transmitted via saliva (11, 21 (Fig. 3) 
